ATE252913T1 - Vorbeugung einer krankheit mit diabetes charakter - Google Patents
Vorbeugung einer krankheit mit diabetes charakterInfo
- Publication number
- ATE252913T1 ATE252913T1 AT96921919T AT96921919T ATE252913T1 AT E252913 T1 ATE252913 T1 AT E252913T1 AT 96921919 T AT96921919 T AT 96921919T AT 96921919 T AT96921919 T AT 96921919T AT E252913 T1 ATE252913 T1 AT E252913T1
- Authority
- AT
- Austria
- Prior art keywords
- diabetes
- prevention
- type disease
- type
- disease
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK76595 | 1995-06-30 | ||
| PCT/DK1996/000297 WO1997002043A1 (en) | 1995-06-30 | 1996-07-01 | Prevention of a disease having the characteristics of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE252913T1 true ATE252913T1 (de) | 2003-11-15 |
Family
ID=8097303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96921919T ATE252913T1 (de) | 1995-06-30 | 1996-07-01 | Vorbeugung einer krankheit mit diabetes charakter |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6274549B1 (de) |
| EP (1) | EP0835129B1 (de) |
| JP (1) | JPH11509195A (de) |
| AT (1) | ATE252913T1 (de) |
| AU (1) | AU6299596A (de) |
| DE (1) | DE69630527T2 (de) |
| WO (1) | WO1997002043A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ506447A (en) * | 1998-02-23 | 2002-11-26 | Neurocrine Biosciences Inc | Peptide analogues of insulin with alanine substitutions and pharmaceutical use |
| AU781405B2 (en) * | 1998-02-23 | 2005-05-19 | Neurocrine Biosciences, Inc. | Methods for treatment of diabetes using peptide analogues of insulin |
| US6562942B1 (en) * | 1999-02-23 | 2003-05-13 | Neurocrine Biosciences, Inc. | Methods for treatment of diabetes using peptide analogues of insulin |
| JPH11353404A (ja) * | 1998-06-11 | 1999-12-24 | Hitachi Ltd | 電子カルテシステム |
| EP2368579A1 (de) | 2004-01-21 | 2011-09-28 | Novo Nordisk Health Care AG | Tranglutaminase vermittelte konjugation von peptiden. |
| MX2007000883A (es) | 2004-07-19 | 2007-04-02 | Biocon Ltd | Conjugados de insulina-oligomero, formulaciones y usos de los mismos. |
| BRPI0818004B8 (pt) | 2007-10-16 | 2021-05-25 | Biocon Ltd | composição farmacêutica sólida administrável por via oral e o processo da mesma. |
| MX2010009850A (es) | 2008-03-18 | 2010-09-30 | Novo Nordisk As | Analogos de insulina acilados y etabilizados contra proteasas. |
| CN104884064A (zh) | 2012-12-24 | 2015-09-02 | 纽洛佳斯特拉斯公司 | 用于治疗胃肠道病症的方法 |
| US9844554B2 (en) | 2014-06-24 | 2017-12-19 | Neurogastrx, Inc. | Prodrugs of metopimazine |
| MA49116A (fr) | 2016-12-16 | 2020-03-25 | Novo Nordisk As | Compositions pharmaceutiques contenant de l'insuline |
| US10836757B1 (en) | 2020-04-02 | 2020-11-17 | Neurogastrx, Inc. | Polymorphic forms of metopimazine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99699A (en) * | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
| US5422339A (en) | 1991-03-19 | 1995-06-06 | Joslin Diabetes Center, Inc. | Peptides having insulin autoantibody but not insulin receptor binding capacity |
| US5891435A (en) * | 1993-04-16 | 1999-04-06 | Research Corporation Technologies, Inc. | Methods and compositions for delaying or preventing the onset of autoimmune disease |
| US5725860A (en) | 1994-03-07 | 1998-03-10 | Auckland Uniservices Limited | Method for reducing the risk of developing diabetes |
| US5461031A (en) * | 1994-06-16 | 1995-10-24 | Eli Lilly And Company | Monomeric insulin analog formulations |
| US5474978A (en) * | 1994-06-16 | 1995-12-12 | Eli Lilly And Company | Insulin analog formulations |
| WO1997009061A1 (en) | 1995-09-06 | 1997-03-13 | Alexion Pharmaceuticals, Inc. | Treatment of diabetes via administration of hormonally ineffective insulin |
-
1996
- 1996-07-01 AT AT96921919T patent/ATE252913T1/de not_active IP Right Cessation
- 1996-07-01 AU AU62995/96A patent/AU6299596A/en not_active Abandoned
- 1996-07-01 DE DE69630527T patent/DE69630527T2/de not_active Expired - Fee Related
- 1996-07-01 EP EP96921919A patent/EP0835129B1/de not_active Expired - Lifetime
- 1996-07-01 JP JP9504729A patent/JPH11509195A/ja active Pending
- 1996-07-01 WO PCT/DK1996/000297 patent/WO1997002043A1/en not_active Ceased
- 1996-07-01 US US09/319,138 patent/US6274549B1/en not_active Expired - Fee Related
-
2001
- 2001-05-02 US US09/847,623 patent/US20010021696A1/en not_active Abandoned
- 2001-06-01 US US09/872,923 patent/US20010041669A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE69630527D1 (de) | 2003-12-04 |
| US20010021696A1 (en) | 2001-09-13 |
| US6274549B1 (en) | 2001-08-14 |
| EP0835129A1 (de) | 1998-04-15 |
| US20010041669A1 (en) | 2001-11-15 |
| JPH11509195A (ja) | 1999-08-17 |
| EP0835129B1 (de) | 2003-10-29 |
| AU6299596A (en) | 1997-02-05 |
| WO1997002043A1 (en) | 1997-01-23 |
| DE69630527T2 (de) | 2004-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE252913T1 (de) | Vorbeugung einer krankheit mit diabetes charakter | |
| DE10199020I2 (de) | Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit. | |
| DE3889536D1 (de) | Behandlung von krebs mit somatostatin und mit analogen davon. | |
| GB2267441B (en) | Bandage | |
| SE9500639L (sv) | Assistansbordspåse | |
| TR200000134T2 (tr) | Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi. | |
| ATE258797T1 (de) | Verwendung von amifostin | |
| BR9810444A (pt) | Tratamento de diabete com rosiglitazona e insulina | |
| KR920700625A (ko) | 고혈압 치료를 위한 신장에 선택적인 프로드러그(Prodrug) | |
| DE69106777D1 (de) | Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination. | |
| AU2940795A (en) | Use of igf-i or analogues thereof in the prevention of diabetes | |
| GR3018651T3 (en) | Treatment of ocular hypertention with a synergistic combination | |
| ATE289819T1 (de) | Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta- estern desselben | |
| BR9713349A (pt) | Método e dispositivo para adaptar uma estrutura de ponte para ajustar elementos de ancoragem em uma mandìbula de paciente. | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| FI972674L (fi) | 3,3-(disubstituoituja)sykloheksan-1-olimonomeerejä ja vastaavia yhdisteitä | |
| IT9048106A0 (it) | Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516) | |
| IT8921236A0 (it) | Procedimento per produrre pezzi stampati e dispositivo per l'esecuzione del procedimento. | |
| ATE198476T1 (de) | Alternative kristallform von tazofelon ((+,-)-5- ((3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl)methyl)-4-thiazolidinon) | |
| DE69101077D1 (de) | System und Verfahren zum Zusammenbau einer Orthese. | |
| IT8603418A1 (it) | Calzatura anatomica per la prevenzione e la correzione dell'alluce valgo. | |
| BR9401034C1 (pt) | Dispositivo de desarme automático para hastes subsoladoras | |
| IT217654Z2 (it) | Chiusura micrometrica a gancio per stivali da motocross e calzature simili. | |
| ATE98127T1 (de) | Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation. | |
| FI950981L (fi) | Hiirialusta |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |